Event
DR. ALAN SCHNEYER, PhD, CEO and Chief Scientific Officer Fairbanks Pharmaceuticals
Monday, April 15, 2019 12:00to13:00
Seminar Announcement
DR. ALAN SCHNEYER, PhD
CEO and Chief Scientific Officer
Fairbanks Pharmaceuticals
Title : "FSTL3 neutralizing antibody as a novel diabetes therapy"
Seminar :
Monday, April 15 , 2019
12pm - 1pm
McIntyre Medical Sciences Building
Room 1345